Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 638
Filter
Add more filters

Publication year range
1.
Bioorg Chem ; 150: 107497, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38852311

ABSTRACT

New derivatives of tropane scaffold were prepared from the reaction of their thione or thioamide derivatives with α-halocarbonyl compounds. The structures of all new derivatives were assured and proved with their spectral data. The novel tropane derivatives were examined for their cytotoxicity on two colon tumor cell lines; Caco2 and HCT116 cells. The most active compounds 3, 4, 5, 9d and 14a displayed significant antitumor activities with IC50 range of 9.50 - 30.15 µM compared to doxorubicin. Moreover, they revealed reduced cytotoxic effect on WI-38 normal ones, signifying their great safety. With the aim of better understanding the inhibitory potential of such compounds on heat-shock protein 90 (Hsp90), there activities were assessed against such enzyme demonstrating high inhibitory activities with IC50 range of 56.58-78.85 nM. Western blotting was carried out to ensure the inhibitory activity on Hsp90, results showed that 3 markedly suppressed Hsp90 expression on Caco2 cell line. Additionally, a molecular docking analysis of the most potent derivatives at the Hsp90 binding site was carried out in order to approve the performed in vitro assays.


Subject(s)
Antineoplastic Agents , Colonic Neoplasms , Drug Screening Assays, Antitumor , HSP90 Heat-Shock Proteins , Molecular Docking Simulation , Tropanes , Humans , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Colonic Neoplasms/drug therapy , Colonic Neoplasms/pathology , Colonic Neoplasms/metabolism , Dose-Response Relationship, Drug , HSP90 Heat-Shock Proteins/antagonists & inhibitors , HSP90 Heat-Shock Proteins/metabolism , Molecular Structure , Structure-Activity Relationship , Tropanes/pharmacology , Tropanes/chemistry , Tropanes/chemical synthesis , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology
2.
Pharmacol Rev ; 71(4): 450-466, 2019 10.
Article in English | MEDLINE | ID: mdl-31471460

ABSTRACT

Despite continuous clinical use for more than 170 years, the mechanism of general anesthetics has not been completely characterized. In this review, we focus on the role of voltage-gated sodium channels in the sedative-hypnotic actions of halogenated ethers, describing the history of anesthetic mechanisms research, the basic neurobiology and pharmacology of voltage-gated sodium channels, and the evidence for a mechanistic interaction between halogenated ethers and sodium channels in the induction of unconsciousness. We conclude with a more integrative perspective of how voltage-gated sodium channels might provide a critical link between molecular actions of the halogenated ethers and the more distributed network-level effects associated with the anesthetized state across species.


Subject(s)
Ethers/pharmacology , Unconsciousness/chemically induced , Unconsciousness/metabolism , Voltage-Gated Sodium Channels/metabolism , Animals , Ethers/chemistry , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Hypnotics and Sedatives/chemistry , Hypnotics and Sedatives/pharmacology
3.
Int J Mol Sci ; 23(3)2022 Jan 25.
Article in English | MEDLINE | ID: mdl-35163284

ABSTRACT

Heart disease requires a surgical approach sometimes. Cardiac-surgery patients develop heart failure associated with ischemia induced during extracorporeal circulation. This complication could be decreased with anesthetic drugs. The cardioprotective effects of halogenated agents are based on pre- and postconditioning (sevoflurane, desflurane, or isoflurane) compared to intravenous hypnotics (propofol). We tried to put light on the shadows walking through the line of the halogenated anesthetic drugs' effects in several enzymatic routes and oxidative stress, waiting for the final results of the ACDHUVV-16 clinical trial regarding the genetic modulation of this kind of drugs.


Subject(s)
Cardiac Surgical Procedures/mortality , Heart Failure/etiology , Hydrocarbons, Halogenated/pharmacology , Anesthetics, Inhalation/pharmacology , Cardiac Surgical Procedures/methods , Cardiomyopathies/drug therapy , Cardiomyopathies/surgery , Cardiotonic Agents/pharmacology , Heart Failure/mortality , Humans , Isoflurane/pharmacology , Myocardium/pathology , Oxidative Stress/physiology , Propofol/pharmacology , Sevoflurane/pharmacology
4.
Molecules ; 26(24)2021 Dec 16.
Article in English | MEDLINE | ID: mdl-34946717

ABSTRACT

Antimicrobial resistance is one of the current public health challenges to be solved. The World Health Organization (WHO) has urgently called for the development of strategies to expand the increasingly limited antimicrobial arsenal. The development of anti-virulence therapies is a viable option to counteract bacterial infections with the possibility of reducing the generation of resistance. Here we report on the chemical structures of pyrrolidones DEXT 1-4 (previously identified as furan derivatives) and their anti-virulence activity on Pseudomonas aeruginosa strains. DEXT 1-4 were shown to inhibit biofilm formation, swarming motility, and secretion of ExoU and ExoT effector proteins. Also, the anti-pathogenic property of DEXT-3 alone or in combination with furanone C-30 (quorum sensing inhibitor) or MBX-1641 (type III secretion system inhibitor) was analyzed in a model of necrosis induced by P. aeruginosa PA14. All treatments reduced necrosis; however, only the combination of C-30 50 µM with DEXT-3 100 µM showed significant inhibition of bacterial growth in the inoculation area and systemic dispersion. In conclusion, pyrrolidones DEXT 1-4 are chemical structures capable of reducing the pathogenicity of P. aeruginosa and with the potential for the development of anti-virulence combination therapies.


Subject(s)
Anti-Bacterial Agents , Furans , Hydrocarbons, Halogenated , Pseudomonas Infections , Pseudomonas aeruginosa , Pyrrolidinones , Type III Secretion Systems/antagonists & inhibitors , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Furans/chemistry , Furans/pharmacology , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Mice , Necrosis , Pseudomonas Infections/drug therapy , Pseudomonas Infections/metabolism , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/pathogenicity , Pyrrolidinones/chemistry , Pyrrolidinones/pharmacology , Quorum Sensing/drug effects , Type III Secretion Systems/metabolism , Virulence Factors/metabolism
5.
Angew Chem Int Ed Engl ; 60(41): 22376-22384, 2021 10 04.
Article in English | MEDLINE | ID: mdl-34289230

ABSTRACT

Small organic photothermal agents (SOPTAs) that absorb in the second near-infrared (NIR-II, 1000-1700 nm) window are highly desirable in photothermal therapy for their good biocompatibility and deeper tissue penetration. However, the design of NIR-II absorbing SOPTAs remains a great challenge. Herein, we report that molecular engineering of BF2 complex via strengthening the donor-acceptor conjugation and increasing the intramolecular motions is an efficient strategy to achieve NIR-II absorbing SOPTAs with high photothermal performance. Based on this strategy, a BF2 complex, BAF4, was designed and synthesized. BAF4 exhibits an intense absorption maximum at 1000 nm and negligible fluorescence. Notably, the nanoparticles of BAF4 achieve a high photothermal conversion efficiency value of 80 % under 1064 nm laser irradiation (0.75 W cm-2 ). In vitro and in vivo studies reveal the great potential of BAF4 nanoparticles in photoacoustic imaging-guided photothermal therapy in the NIR-II window.


Subject(s)
Antineoplastic Agents/pharmacology , Fluorescent Dyes/pharmacology , Hydrocarbons, Halogenated/pharmacology , Photosensitizing Agents/pharmacology , Photothermal Therapy , Animals , Antineoplastic Agents/chemistry , Cell Line, Tumor , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Fluorescent Dyes/chemistry , Humans , Hydrocarbons, Halogenated/chemistry , Infrared Rays , Mice , Molecular Structure , Photosensitizing Agents/chemistry
6.
Chembiochem ; 21(20): 2966-2973, 2020 10 15.
Article in English | MEDLINE | ID: mdl-32473056

ABSTRACT

In the fight against cancer, photodynamic therapy is generating great interest thanks to its ability to selectively kill cancer cells without harming healthy tissues. In this field, ruthenium(II) polypyridyl complexes, and more specifically, complexes with dipyrido[3,2-a:2',3'-c]phenazine (dppz) as a ligand are of particular interest due to their DNA-binding and photocleaving properties. However, ruthenium(II) polypyridyl complexes can sometimes suffer from low lipophilicity, which hampers cellular internalisation through passive diffusion. In this study, four new [Ru(dppz-X2 )3 ]2+ complexes (X=H, F, Cl, Br, I) were synthesized and their lipophilicity (logP), cytotoxicity and phototoxicity on cancerous and noncancerous cell lines were assessed. This study shows that, counterintuitively, the phototoxicity of these complexes decreases as their lipophilicity increases; this could be due solely to the atomic radius of the halogen substituents.


Subject(s)
Antineoplastic Agents/pharmacology , Coordination Complexes/pharmacology , Hydrocarbons, Halogenated/pharmacology , Photochemotherapy , Photosensitizing Agents/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Cell Proliferation/drug effects , Cells, Cultured , Coordination Complexes/chemical synthesis , Coordination Complexes/chemistry , Halogenation , Humans , Hydrocarbons, Halogenated/chemical synthesis , Hydrocarbons, Halogenated/chemistry , Hydrophobic and Hydrophilic Interactions , Ligands , Molecular Structure , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/chemistry , Pyridines/chemistry , Pyridines/pharmacology , Ruthenium/chemistry , Ruthenium/pharmacology , Singlet Oxygen/metabolism
7.
Chem Res Toxicol ; 33(9): 2401-2407, 2020 09 21.
Article in English | MEDLINE | ID: mdl-32803957

ABSTRACT

Disinfecting drinking water with chlorine inadvertently generates disinfection byproducts (DBPs) which can cause potential adverse health effects to humans. Haloaromatic DBPs are a group of emerging DBPs recently identified, suspected to be substantially more toxic than haloaliphatic DBPs but have not been extensively studied. Simultaneously, service pipelines made of lead materials are widely used in water distribution systems and become a source of dissolved lead (Pb) in tap water. In this study, we investigated the cytotoxicity of nine haloaromatic DBPs and lead ion (Pb2+), both separately as well as in combination, to human epithelial colorectal adenocarcinoma (Caco-2) and neuroblastoma (SH-SY5Y) cells. Results show that the cytotoxicity of the DBPs against Caco-2 cells followed the descending rank order of 2,4,6-triiodophenol ≅ 2,5-dibromohydroquinone > 2,4,6-tribromophenol > 3,5-dibromo-4-hydroxybenzaldehyde ≅ 2,4,6-trichlorophenol > 4-chlorophenol ≅ 3,5-dibromo-4-hydroxybenzoic acid > 2,6-dichlorophenol >5-chlorosalicylic acid, and the cytotoxicity of the DBPs against SH-SY5Y cells followed a similar rank order, 2,4,6-triiodophenol ≅ 2,5-dibromohydroquinone > 2,4,6-tribromophenol > 3,5-dibromo-4-hydroxybenzaldehyde ≅ 2,4,6-trichlorophenol > 4-chlorophenol > 3,5-dibromo-4-hydroxybenzoic acid > 2,6-dichlorophenol ≅ 5-chlorosalicylic acid. Lead in water did not change the toxicity of 3,5-dibromo-4-hydroxybenzoic acid (to either cell-type) or the toxicity of 4-chlorophenol (to the neuronal cell-type); but Pb2+ exhibited different degrees of synergistic effects with other tested DBPs. The synergism resulted in different rank orders of cytotoxicity against both intestinal and neuronal cells. These data indicate that future prioritization and regulation of emerging haloaromatic DBPs in drinking water should be considered in terms of their own toxicity and combinatorial effects with lead in water.


Subject(s)
Disinfectants/pharmacology , Hydrocarbons, Halogenated/pharmacology , Intestine, Small/drug effects , Lead/pharmacology , Neurons/drug effects , Caco-2 Cells , Cells, Cultured , Disinfectants/administration & dosage , Dose-Response Relationship, Drug , Humans , Hydrocarbons, Halogenated/administration & dosage , Lead/administration & dosage
8.
Bioorg Chem ; 105: 104418, 2020 12.
Article in English | MEDLINE | ID: mdl-33166844

ABSTRACT

A novel series of halogenated triarylpyrazoles 12a-l was designed and synthesized. All target compounds showed good in vitro COX-2 inhibitory activity (IC50 = 0.043-0.17 µM) over COX-1 (IC50 = 7.8 - 15.4 µM) relative to celecoxib (COX-1/IC50 = 9.87, COX-2/IC50 = 0.055), with acceptable selectivity index values (SI = 50.6-253.1). Also, they displayed moderate to potent in vivo anti-inflammatory activity (% edema inhibition = 16.9-87.9) comparable to celecoxib (% edema inhibition = 46.6-72.1) as standard drug. Three fluorinated pyrazoles 12a, 12g and 12j, exhibited superior anti-inflammatory activity at all time intervals (% edema inhibition = 42.1-87.9) with better gastric profile (UI = 1.25-2.5) than the traditional NSAID; indomethacin (UI = 14) and were close to the selective COX-2 inhibitor; celecoxib (UI = 1.75). In-silico docking and ADME studies of 12a, 12g and 12j supported the obtained biological data and pointed out their potential use for the development of bio-available, safe and potent anti-inflammatory drugs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2/metabolism , Edema/drug therapy , Hydrocarbons, Halogenated/pharmacology , Pyrazoles/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/chemical synthesis , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Carrageenan , Cyclooxygenase 2 Inhibitors/chemical synthesis , Cyclooxygenase 2 Inhibitors/chemistry , Dose-Response Relationship, Drug , Edema/chemically induced , Edema/pathology , Humans , Hydrocarbons, Halogenated/chemical synthesis , Hydrocarbons, Halogenated/chemistry , Molecular Docking Simulation , Molecular Structure , Pyrazoles/chemical synthesis , Pyrazoles/chemistry , Rats , Stomach Ulcer/drug therapy , Stomach Ulcer/pathology , Structure-Activity Relationship
9.
Alzheimers Dement ; 16(10): 1345-1357, 2020 10.
Article in English | MEDLINE | ID: mdl-32918367

ABSTRACT

The hallmark pathologies of the Alzheimer's disease (AD) brain are amyloid beta (Aß)-containing senile plaques and neurofibrillary tangles formed from the microtubule (MT)-binding tau protein. Tau becomes hyperphosphorylated and disengages from MTs in AD, with evidence of resulting MT structure/function defects. Brain-penetrant MT-stabilizing compounds can normalize MTs and axonal transport in mouse models with tau pathology, thereby reducing neuron loss and decreasing tau pathology. MT dysfunction is also observed in dystrophic axons adjacent to Aß plaques, resulting in accumulation of amyloid precursor protein (APP) and BACE1 with the potential for enhanced localized Aß generation. We have examined whether the brain-penetrant MT-stabilizing compound CNDR-51657 might decrease plaque-associated axonal dystrophy and Aß release in 5XFAD mice that develop an abundance of Aß plaques. Administration of CNDR-51657 to 1.5-month-old male and female 5XFAD mice for 4 or 7 weeks led to decreased soluble brain Aß that coincided with reduced APP and BACE1 levels, resulting in decreased formation of insoluble Aß deposits. These data suggest a vicious cycle whereby initial Aß plaque formation causes MT disruption in nearby axons, resulting in the local accumulation of APP and BACE1 that facilitates additional Aß generation and plaque deposition. The ability of a MT-stabilizing compound to attenuate this cycle, and also reduce deficits resulting from reduced tau binding to MTs, suggests that molecules of this type hold promise as potential AD therapeutics.


Subject(s)
Axons/pathology , Brain/drug effects , Hydrocarbons, Halogenated/pharmacology , Microtubules/drug effects , Plaque, Amyloid/pathology , Triazoles/pharmacology , Amyloid beta-Peptides/metabolism , Animals , Brain/metabolism , Brain/pathology , Disease Models, Animal , Female , Humans , Male , Mice , Mice, Transgenic , Microtubules/pathology
10.
Molecules ; 25(4)2020 Feb 19.
Article in English | MEDLINE | ID: mdl-32093094

ABSTRACT

The enzymatic synthesis of nucleoside analogues has been shown to be a sustainable and efficient alternative to chemical synthesis routes. In this study, dihalogenated nucleoside analogues were produced by thermostable nucleoside phosphorylases in transglycosylation reactions using uridine or thymidine as sugar donors. Prior to the enzymatic process, ideal maximum product yields were calculated after the determination of equilibrium constants through monitoring the equilibrium conversion in analytical-scale reactions. Equilibrium constants for dihalogenated nucleosides were comparable to known purine nucleosides, ranging between 0.071 and 0.081. To achieve 90% product yield in the enzymatic process, an approximately five-fold excess of sugar donor was needed. Nucleoside analogues were purified by semi-preparative HPLC, and yields of purified product were approximately 50% for all target compounds. To evaluate the impact of halogen atoms in positions 2 and 6 on the antiproliferative activity in leukemic cell lines, the cytotoxic potential of dihalogenated nucleoside analogues was studied in the leukemic cell line HL-60. Interestingly, the inhibition of HL-60 cells with dihalogenated nucleoside analogues was substantially lower than with monohalogenated cladribine, which is known to show high antiproliferative activity. Taken together, we demonstrate that thermodynamic calculations and small-scale experiments can be used to produce nucleoside analogues with high yields and purity on larger scales. The procedure can be used for the generation of new libraries of nucleoside analogues for screening experiments or to replace the chemical synthesis routes of marketed nucleoside drugs by enzymatic processes.


Subject(s)
Antineoplastic Agents , Hydrocarbons, Halogenated , Leukemia/drug therapy , Purine Nucleosides , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , HL-60 Cells , Humans , Hydrocarbons, Halogenated/chemical synthesis , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Leukemia/metabolism , Leukemia/pathology , Pentosyltransferases/chemistry , Purine Nucleosides/chemical synthesis , Purine Nucleosides/chemistry , Purine Nucleosides/pharmacology , Thermodynamics
11.
Biochem Biophys Res Commun ; 516(3): 760-764, 2019 08 27.
Article in English | MEDLINE | ID: mdl-31253401

ABSTRACT

We report the utility of cevipabulin as a stabilizing agent for microtubules. Cevipabulin-stabilized microtubules were more flexible compared to the microtubules stabilized by paclitaxel, the most commonly used microtubule stabilizing agent. Similar to the paclitaxel-stabilized microtubules, cevipabulin-stabilized microtubules were driven by kinesins in an in vitro gliding assay. The velocity of cevipabulin-stabilized microtubules was significantly higher than that of paclitaxel-stabilized microtubules. These findings will enrich the variety of microtubules with difference in mechanical and dynamic properties and widen their applications in nanotechnology.


Subject(s)
Hydrocarbons, Halogenated/metabolism , Microtubules/metabolism , Molecular Docking Simulation , Triazoles/metabolism , Tubulin/metabolism , Animals , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Microscopy, Fluorescence , Molecular Structure , Nanotechnology , Paclitaxel/chemistry , Paclitaxel/metabolism , Paclitaxel/pharmacology , Protein Stability/drug effects , Swine , Time-Lapse Imaging/methods , Triazoles/chemistry , Triazoles/pharmacology
12.
Chembiochem ; 20(2): 282-286, 2019 01 18.
Article in English | MEDLINE | ID: mdl-30474907

ABSTRACT

Deubiquitinases are important components of the protein regulatory network and, hence, constitute a tempting drug target. We report herein structure-activity relationship studies to develop halogen-substituted isoquionoline-1,3-dione-based inhibitors of the deubiquitinase USP2. In contrast to our previous reports, the best compound discovered was found to act through a reactive oxygen species independent, uncompetitive mechanism with an IC50 of 250 nm. We show the crucial role of halogens in the common scaffold to provide potency and selectivity of our compound, where the introduction of the fluorine atom completely switches the selectivity of the inhibitor between USP2 and USP7. Our cellular studies highlight the potential applicability of the reported compound for in vivo experiments. The discovery of the isoquinoline-1,3-dione core and the knowledge obtained with regard to halogen substituents provide a platform towards understanding USP2 inhibition and the development of highly selective next-generation deubiquitinase inhibitors.


Subject(s)
Endopeptidases/metabolism , Halogens/pharmacology , Hydrocarbons, Halogenated/pharmacology , Isoquinolines/pharmacology , Ubiquitin-Specific Peptidase 7/antagonists & inhibitors , Carbohydrate Conformation , Dose-Response Relationship, Drug , Halogens/chemistry , HeLa Cells , High-Throughput Screening Assays , Humans , Hydrocarbons, Halogenated/chemistry , Isoquinolines/chemistry , Molecular Structure , Structure-Activity Relationship , Ubiquitin Thiolesterase , Ubiquitin-Specific Peptidase 7/metabolism
13.
Mar Drugs ; 17(4)2019 Apr 17.
Article in English | MEDLINE | ID: mdl-30999651

ABSTRACT

The subtidal red alga Plocamium cartilagineum was collected from the Western Antarctic Peninsula during the 2011 and 2017 austral summers. Bulk collections from specific sites corresponded to chemogroups identified by Young et al. in 2013. One of the chemogroups yielded several known acyclic halogenated monoterpenes (2-5) as well as undescribed compounds of the same class, anverenes B-D (6-8). Examination of another chemogroup yielded an undescribed cyclic halogenated monoterpene anverene E (9) as its major secondary metabolite. Elucidation of structures was achieved through one-dimensional (1D) and 2D nuclear magnetic resonance (NMR) spectroscopy and negative chemical ionization mass spectrometry. Compounds 1-9 show moderate cytotoxicity against cervical cancer (HeLa) cells.


Subject(s)
Monoterpenes/chemistry , Monoterpenes/pharmacology , Plocamium/chemistry , Antarctic Regions , Cell Line, Tumor , Cell Survival/drug effects , HeLa Cells , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/isolation & purification , Hydrocarbons, Halogenated/pharmacology , Inhibitory Concentration 50 , Molecular Conformation , Monoterpenes/isolation & purification , Nuclear Magnetic Resonance, Biomolecular
14.
Mar Drugs ; 17(7)2019 Jul 19.
Article in English | MEDLINE | ID: mdl-31330960

ABSTRACT

Red algae of the genus Plocamium have been a rich source of halogenated monoterpenes. Herein, a new cyclic monoterpene, costatone C (7), was isolated from the extract of P. angustum collected in New Zealand, along with the previously reported (1E,5Z)-1,6-dichloro-2-methylhepta-1,5-dien-3-ol (8). Elucidation of the planar structure of 7 was achieved through conventional NMR and (-)-HR-APCI-MS techniques, and the absolute configuration by comparison of experimental and DFT-calculated ECD spectra. The absolute configuration of 8 was determined using Mosher's method. Compound 7 showed mild antibacterial activity against Staphylococcus aureus and S. epidermidis. The state of Plocamium taxonomy and its implications upon natural product distributions, especially across samples from specimens collected in different countries, is also discussed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Hydrocarbons, Halogenated/pharmacology , Monoterpenes/pharmacology , Plant Extracts/chemistry , Plocamium/chemistry , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/isolation & purification , Magnetic Resonance Spectroscopy , Microbial Sensitivity Tests , Molecular Structure , Monoterpenes/chemistry , Monoterpenes/isolation & purification , New Zealand , Plant Extracts/isolation & purification , Staphylococcus aureus/drug effects , Staphylococcus epidermidis/drug effects
15.
Mar Drugs ; 17(2)2019 Jan 22.
Article in English | MEDLINE | ID: mdl-30678253

ABSTRACT

Macroalgae have been reported as an important source of halogenated aromatic secondary metabolites, being the majority of these derivatives isolated from red algae. Halophenols and haloindoles are the most common haloaryl secondary metabolites isolated from these marine organisms. Nevertheless, some halogenated aromatic sesquiterpenes and naphthalene derivatives have also been isolated. Most of these secondary metabolites showed interesting biological activities, such as antitumor, antimicrobial, antidiabetic, and antioxidant. This review describes in a systematic way the distribution and natural occurrence of halogenated aromatic secondary metabolites from extracts of red, brown, and green algae, as well as biological activities reported for these compounds.


Subject(s)
Anti-Bacterial Agents/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Seaweed/chemistry , Seaweed/metabolism , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/metabolism , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/metabolism , Chlorophyta/chemistry , Chlorophyta/metabolism , Molecular Structure , Phaeophyceae/chemistry , Phaeophyceae/metabolism , Rhodophyta/chemistry , Rhodophyta/metabolism
16.
J Biochem Mol Toxicol ; 32(2)2018 Feb.
Article in English | MEDLINE | ID: mdl-29243863

ABSTRACT

In this study, three substituted polyhalogenated nitrobutadiene derivatives were synthesized. Compound 1-[(2,3-dibromopropyl)sulfanyl]-1,3,4,4-tetrachloro-2-nitrobuta-1,3-diene (4) was synthesized before by our group. Compounds 8-{[1-[(2,3-dibromopropyl)sulfany]-3,4,4-trichloro-2-nitrobuta-1,3-butadien-1-yl}-1,4-dioxa-8-azaspiro[4.5]decane (5) and 1-[(2,3-dibromopropyl)sulfanyl]-3,4,4-trichloro-N-(4-methylpiperazin-1-yl)-2-nitrobuta-1,3-diene-1-amine (6) were synthesized in this work as original compounds. Xanthine oxidase, elastase inhibition abilities, and antioxidant activities were investigated in this work for compounds 4, 5, and 6. In this study, compounds 4, 5, and 6 exhibited antixanthine oxidase, antielastase, and antioxidant activities. Among the compounds screened, compound 4 exhibited xanthine oxidase and elastase inhibitor effect similar to the standard compound. Among the three tested compounds, compound 6 showed potent DPPH radical scavenging and reducing power activities. Therefore, these three compounds (4, 5, and 6) may be useful as an antixanthine oxidase, antielastase, and antioxidant agent in pharmaceutical and cosmetic industry.


Subject(s)
Antioxidants/pharmacology , Butadienes/pharmacology , Enzyme Inhibitors/pharmacology , Hydrocarbons, Halogenated/pharmacology , Leukocyte Elastase/antagonists & inhibitors , Serine Proteinase Inhibitors/pharmacology , Xanthine Oxidase/antagonists & inhibitors , Antioxidants/chemical synthesis , Antioxidants/chemistry , Butadienes/chemical synthesis , Butadienes/chemistry , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Free Radical Scavengers/chemical synthesis , Free Radical Scavengers/chemistry , Free Radical Scavengers/pharmacology , Gout Suppressants/chemical synthesis , Gout Suppressants/chemistry , Gout Suppressants/pharmacology , Humans , Hydrocarbons, Halogenated/chemical synthesis , Hydrocarbons, Halogenated/chemistry , Kinetics , Leukocyte Elastase/metabolism , Molecular Structure , Nootropic Agents/chemical synthesis , Nootropic Agents/chemistry , Nootropic Agents/pharmacology , Serine Proteinase Inhibitors/chemical synthesis , Serine Proteinase Inhibitors/chemistry , Transition Temperature , Xanthine Oxidase/metabolism
17.
Appl Environ Microbiol ; 82(3): 778-87, 2016 02 01.
Article in English | MEDLINE | ID: mdl-26567308

ABSTRACT

Bromochloromethane (BCM), an inhibitor of methanogenesis, has been used in animal production. However, little is known about its impact on the intestinal microbiota and metabolic patterns. The present study aimed to investigate the effect of BCM on the colonic bacterial community and metabolism by establishing a Wistar rat model. Twenty male Wistar rats were randomly divided into two groups (control and treated with BCM) and raised for 6 weeks. Bacterial fermentation products in the cecum were determined, and colonic methanogens and sulfate-reducing bacteria (SRB) were quantified. The colonic microbiota was analyzed by pyrosequencing of the 16S rRNA genes, and metabolites were profiled by gas chromatography and mass spectrometry. The results showed that BCM did not affect body weight and feed intake, but it did significantly change the intestinal metabolic profiles. Cecal protein fermentation was enhanced by BCM, as methylamine, putrescine, phenylethylamine, tyramine, and skatole were significantly increased. Colonic fatty acid and carbohydrate concentrations were significantly decreased, indicating the perturbation of lipid and carbohydrate metabolism by BCM. BCM treatment decreased the abundance of methanogen populations, while SRB were increased in the colon. BCM did not affect the total colonic bacterial counts but significantly altered the bacterial community composition by decreasing the abundance of actinobacteria, acidobacteria, and proteobacteria. The results demonstrated that BCM treatment significantly altered the microbiotic and metabolite profiles in the intestines, which may provide further information on the use of BCM in animal production.


Subject(s)
Gastrointestinal Microbiome/drug effects , Gastrointestinal Microbiome/physiology , Gastrointestinal Tract/microbiology , Hydrocarbons, Halogenated/pharmacology , Metabolome/drug effects , Acidobacteria/drug effects , Acidobacteria/genetics , Acidobacteria/metabolism , Actinobacteria/drug effects , Actinobacteria/genetics , Actinobacteria/metabolism , Animals , Carbohydrate Metabolism/drug effects , Cecum/drug effects , Cecum/metabolism , Cecum/microbiology , Euryarchaeota/classification , Euryarchaeota/drug effects , Euryarchaeota/genetics , Euryarchaeota/metabolism , Fermentation , Gastrointestinal Microbiome/genetics , Gastrointestinal Tract/drug effects , Hydrocarbons, Halogenated/administration & dosage , Intestinal Mucosa/metabolism , Intestines/drug effects , Intestines/microbiology , Lipid Metabolism/drug effects , Metabolome/genetics , Proteobacteria/drug effects , Proteobacteria/genetics , Proteobacteria/metabolism , RNA, Ribosomal, 16S/metabolism , Rats, Wistar , Sequence Analysis, DNA
18.
Neuropsychobiology ; 73(3): 184-90, 2016.
Article in English | MEDLINE | ID: mdl-27221315

ABSTRACT

Vasopressin and CRH have complementary roles in the secretion of ACTH following different stress modalities. The concomitant use of V1b and CRF1 receptor antagonists completely inhibits ACTH secretion in response to different stress modalities. The combination of the CRF1 antagonist SSR125543 with the V1b antagonist SSR149415 effectively suppressed plasma ACTH 1.30 h after injection in rats stressed by ether vapor inhalation for 1 min, restraint stress for 1 h or forced swimming for 5 min. The duration of the effect was also studied. The CRF1 antagonist effectively suppressed ACTH secretion in restraint stress, while the V1b antagonist was effective against ether inhalation. Both antagonists were necessary to block the forced swimming stress response. SSR125543 induced a prolonged effect and can be used in a model of prolonged HPA axis blockade.


Subject(s)
Adrenocorticotropic Hormone/drug effects , Antidiuretic Hormone Receptor Antagonists/pharmacology , Corticotropin-Releasing Hormone/drug effects , Hydrocarbons, Halogenated/pharmacology , Indoles/pharmacology , Pyrrolidines/pharmacology , Stress, Psychological/metabolism , Thiazines/pharmacology , Vasopressins/drug effects , Administration, Inhalation , Adrenocorticotropic Hormone/metabolism , Anesthetics, Inhalation/pharmacology , Animals , Corticotropin-Releasing Hormone/metabolism , Ether/pharmacology , Hypothalamo-Hypophyseal System , Male , Models, Animal , Pituitary-Adrenal System , Rats , Rats, Wistar , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Corticotropin-Releasing Hormone/metabolism , Receptors, Vasopressin/metabolism , Restraint, Physical , Swimming , Vasopressins/metabolism
19.
J Nat Prod ; 79(10): 2674-2680, 2016 10 28.
Article in English | MEDLINE | ID: mdl-27759384

ABSTRACT

Zoanthus kuroshio is a colorful zoanthid with a fluorescent pink oral disc and brown tentacles, which dominates certain parts of the Taiwanese and Japanese coasts. This sea anemone is a rich source of biologically active alkaloids. In the current investigation, two novel halogenated zoanthamines [5α-iodozoanthenamine (1) and 11ß-chloro-11-deoxykuroshine A (2)], along with four new zoanthamines [18-epi-kuroshine A (3), 7α-hydroxykuroshine E (4), 5α-methoxykuroshine E (5), and 18-epi-kuroshine E (6)], and six known compounds were isolated from Z. kuroshio. Compounds 1 and 2 are the first examples of halogenated zoanthamine-type alkaloids isolated from nature. Compounds 3 and 6 are the first zoanthamine stereoisomers with a cis-junction of the A/B rings. All isolated compounds were evaluated for their anti-inflammatory activities by measuring their effects on superoxide anion generation and elastase release by human neutrophils in response to fMLP.


Subject(s)
Alkaloids/isolation & purification , Alkaloids/pharmacology , Anti-Inflammatory Agents/isolation & purification , Azepines/chemistry , Heterocyclic Compounds, 4 or More Rings/chemistry , Hydrocarbons, Halogenated/isolation & purification , Quinolines/chemistry , Sea Anemones/chemistry , Alkaloids/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Japan , Molecular Structure , Neutrophils/metabolism , Pancreatic Elastase/drug effects , Pancreatic Elastase/metabolism , Stereoisomerism , Superoxides/chemistry , Taiwan
20.
J Nat Prod ; 79(3): 463-9, 2016 Mar 25.
Article in English | MEDLINE | ID: mdl-26756908

ABSTRACT

An unusual tetrahalogenated indole with the exceptionally rare inclusion of the three halogens bromine, chlorine, and iodine was found using mass spectrometry within a fraction of a semipurified extract obtained from the red alga Rhodophyllis membranacea. We report herein the isolation and structure elucidation, using a combination of NMR spectroscopy and mass spectrometry, of 11 new tetrahalogenated indoles (1-11), including four bromochloroiodoindoles (5-7, 10). Several were evaluated for cytotoxic and antifungal activities against the HL-60 promyelocytic cell line and Saccharomyces cerevisiae, respectively.


Subject(s)
Antifungal Agents/isolation & purification , Cytotoxins/isolation & purification , Hydrocarbons, Halogenated/isolation & purification , Indoles/isolation & purification , Rhodophyta/chemistry , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Cytotoxins/chemistry , Cytotoxins/pharmacology , Drug Screening Assays, Antitumor , HL-60 Cells , Humans , Hydrocarbons, Halogenated/chemistry , Hydrocarbons, Halogenated/pharmacology , Indoles/chemistry , Indoles/pharmacology , Marine Biology , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Saccharomyces cerevisiae/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL